Expression of HIV-1 Vif and Human APOBEC3G with a Bicistronic Vector

被引:0
|
作者
Yang Yishu [1 ]
Sun Xiaona [1 ]
Liu Di [1 ]
Wang Xiaoli [1 ]
Shen Sisi [1 ]
Li Zelin [1 ]
Zeng Yi [1 ]
机构
[1] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing, Peoples R China
关键词
Human immunodeficiency virus (HIV); apolipoprotein b mRNA editing enzyme-catalytic polypeptide-like 3G (APOBEC3G); viral infectivity factor (Vif); eukaryotic bicistronic vector; ANTIVIRAL ACTIVITY; CYTIDINE DEAMINASE; DNA; PROTEIN; DEGRADATION; HYPERMUTATION; INFECTIVITY; CEM15;
D O I
10.4028/www.scientific.net/AMM.108.141
中图分类号
TH [机械、仪表工业];
学科分类号
0802 ;
摘要
Novel targets against HIV-1 are booming recently. APOBEC3G has the potential to inhibit the replication of HIV-1, while its antiviral activity is counteracted by Vif. The antiviral mechanism of APOBEC3G and the antagonistic mechanism of Vif have drawn great attention. Considering the occurrence of interaction between Vif and APOBEC3G should be based on that these two proteins coexist in the same cells, a eukaryotic bicistronic vector was adopted to express both Vif and APOBEC3G simultaneously. The expression and distribution of Vif and APOBEC3G proteins are detected with fluorescent microscope.
引用
收藏
页码:141 / 145
页数:5
相关论文
共 50 条
  • [41] HIV-1 VIF and human APOBEC3G interaction directly observed through molecular specific labeling using a new dual promotor vector
    Myint, Wazo
    Schiffer, Celia A.
    Matsuo, Hiroshi
    [J]. JOURNAL OF MAGNETIC RESONANCE, 2022, 339
  • [42] Different interaction between HIV-1 Vif and its cellular target proteins APOBEC3G/APOBEC3F
    Nagao, Tamiko
    Yamashita, Tomoki
    Miyake, Ariko
    Uchiyama, Tsuneo
    Nomaguchi, Masako
    Adachi, Akio
    [J]. JOURNAL OF MEDICAL INVESTIGATION, 2010, 57 (1-2): : 89 - 94
  • [43] Evolution of HIV-1 isolates that use a novel Vif-independent mechanism to resist restriction by human APOBEC3G
    Hache, Guylaine
    Shindo, Keisuke
    Albin, John S.
    Harris, Reuben S.
    [J]. CURRENT BIOLOGY, 2008, 18 (11) : 819 - 824
  • [44] Identification of an HIV-1 replication inhibitor which rescues host restriction factor APOBEC3G in Vif-APOBEC3G complex
    Zhang, Shaoyang
    Zhong, Limei
    Chen, Bing
    Pan, Ting
    Zhang, Xue
    Liang, Liting
    Li, Qianwen
    Zhang, Ziying
    Chen, Hui
    Zhou, Jie
    Luo, Haihua
    Zhang, Hui
    Bai, Chuan
    [J]. ANTIVIRAL RESEARCH, 2015, 122 : 20 - 27
  • [45] The Activity Spectrum of Vif from Multiple HIV-1 Subtypes against APOBEC3G, APOBEC3F, and APOBEC3H
    Binka, Mawuena
    Ooms, Marcel
    Steward, Myeika
    Simon, Viviana
    [J]. JOURNAL OF VIROLOGY, 2012, 86 (01) : 49 - 59
  • [46] Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex
    Yu, XH
    Yu, YK
    Liu, BD
    Luo, K
    Kong, W
    Mao, PY
    Yu, XF
    [J]. SCIENCE, 2003, 302 (5647) : 1056 - 1060
  • [47] Identification of amino acid residues in HIV-1 Vif critical for binding and exclusion of APOBEC3G/F
    Yamashita, Tomoki
    Kamada, Kazuya
    Hatcho, Kazuki
    Adachi, Akio
    Nomaguchi, Masako
    [J]. MICROBES AND INFECTION, 2008, 10 (10-11) : 1142 - 1149
  • [48] Status of APOBEC3G/F in cells and progeny virions modulated by Vif determines HIV-1 infectivity
    Yamashita, Tomoki
    Nomaguchi, Masako
    Miyake, Ariko
    Uchiyama, Tsuneo
    Adachi, Akio
    [J]. MICROBES AND INFECTION, 2010, 12 (02) : 166 - 171
  • [49] Functional characterization of Vif proteins from HIV-1 infected patients with different APOBEC3G haplotypes
    Reddy, Kavidha
    Ooms, Marcel
    Letko, Michael
    Garrett, Nigel
    Simon, Viviana
    Ndung'u, Thumbi
    [J]. AIDS, 2016, 30 (11) : 1723 - 1729
  • [50] The interaction between HIV-1 Gag and APOBEC3G
    Cen, S
    Guo, F
    Niu, MJ
    Saadatmand, J
    Deflassieux, J
    Kleiman, L
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (32) : 33177 - 33184